Why should I get atherosclerosis blood testing?

It detects risk before symptoms. ApoB and LDL quantify plaque‑forming particles. Lp(a) uncovers hidden inherited risk. hs‑CRP flags active vascular inflammation. AIP and AC reflect how triglycerides and HDL shape small, dense LDL formation. This integrated view improves risk stratification and helps prioritize next steps long before a heart attack or stroke.

Can I get a blood test at home?

Yes. With Superpower, our team member can organize a professional blood draw in your home and handle all logistics, from scheduling to sample transport, so you get clinical‑grade results without a clinic visit.

How often should I test?

Get a baseline panel. If stable and low risk, annual testing is reasonable. After any therapy change, recheck ApoB/LDL in about 6–12 weeks, then every 3–12 months to confirm trajectory. Measure Lp(a) at least once in a lifetime (it’s genetic). Recheck hs‑CRP when you’re well if a prior result was elevated during illness.

What can affect biomarker levels?

Acute infection, injury, or surgery can raise hs‑CRP. Recent heavy exercise, alcohol, or a large meal can shift triglycerides and thus AIP and AC. Fasting status affects triglycerides. Medications, thyroid status, diabetes control, kidney or liver disease, pregnancy, and smoking influence LDL and ApoB. Lp(a) is largely genetic and stable across day‑to‑day factors.

Are there any preparations needed before the blood test for LDL, ApoB, Lp(a), hs‑CRP, AIP, AC?

Fasting 8–12 hours is ideal for accurate triglycerides, which improves AIP and AC. Schedule testing when you’re well, not during infection or flare, to avoid spurious hs‑CRP elevations. Avoid unusually strenuous exercise and heavy alcohol the day before. Stay hydrated. Take your usual medications unless your clinician has given different instructions.

Can lifestyle changes affect my biomarker levels?

Yes. LDL and ApoB typically respond to metabolic changes and prescribed therapies. AIP and AC track with triglycerides and HDL shifts. hs‑CRP reflects overall inflammatory tone and can fall when systemic inflammation is lower. Lp(a) is mostly genetic and tends not to change with lifestyle, so it serves as a stable, baseline risk marker.

Atherosclerosis: Biomarkers for Plaque and Vascular Risk

Creator: Superpower
Published: 2025-11-06

Understand what your heart cardiovascular testing results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

Atherosclerosis and the particle, inflammation, and inheritance signals

Atherosclerosis biomarkers are blood signals that reveal how actively plaque is forming and how risky it may be, often years before symptoms. They illuminate three core processes. First, the traffic of cholesterol‑laden particles that enter artery walls (apoB‑containing lipoproteins such as LDL and remnant particles), including a particularly sticky, inherited form (lipoprotein(a), Lp(a)). Second, the vessel wall’s inflammatory state, which drives plaque growth and fragility (high‑sensitivity C‑reactive protein, hs‑CRP, and other inflammatory mediators). Third, the readiness of blood to clot if a plaque ruptures (prothrombotic factors like fibrinogen and platelet activation markers). Together, these markers offer a dynamic picture of arterial injury, repair, and risk—not just a snapshot of cholesterol. Testing helps identify people whose plaques are likely to progress or rupture, guides the intensity and type of treatment, and tracks whether therapies are calming inflammation and reducing atherogenic particle burden. In short, atherosclerosis biomarkers translate invisible artery biology into actionable information.

Why particle count beats cholesterol alone

Atherosclerosis biomarkers are blood signals that reveal how aggressively cholesterol-carrying particles and inflammation interact with your artery walls. They map the pressure on the endothelium, the tendency to form plaque, and the stability of that plaque—processes that shape oxygen delivery to the heart, brain, kidneys, and limbs long before symptoms appear. LDL and ApoB quantify the atherogenic “traffic” in your bloodstream; ApoB reflects particle number, which drives plaque entry. Lp(a) adds inherited “stickiness” and thrombosis risk. hs-CRP captures vessel-wall inflammation. Composite ratios like AIP and AC integrate triglycerides, HDL, and total cholesterol to estimate particle atherogenicity. Reference intervals vary by lab, but cardiovascular risk generally falls as LDL, ApoB, Lp(a), hs-CRP, AIP, and AC move toward the lower end; higher values point to more particle burden, inflammation, and plaque growth. Many people feel fine until angina, transient neurologic symptoms, erectile dysfunction, or exertional calf pain signal advanced disease. When these markers are low, physiology tilts toward endothelial healing: fewer apoB-containing particles cross into the wall, less oxidized lipid accumulates, and inflammation quiets. Low Lp(a) indicates minimal inherited contribution. Very low lipid values can occur with hyperthyroidism, malabsorption, or serious illness. Children typically sit lower; pregnancy raises LDL, ApoB, and Lp(a); premenopausal women often have lower ApoB/LDL than men, with values rising after menopause. Big picture: this panel links lipid transport, inflammation, coagulation, and vascular biology. Tracked over time and interpreted with blood pressure, glucose and insulin status, kidney and thyroid function, it refines lifetime risk for heart attack, stroke, and peripheral vascular disease by showing how your arteries are coping right now.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What a blood panel reveals about artery health

Atherosclerosis blood testing provides a window into the health of your arteries and the systems they support, including your heart, brain, and metabolic function. When arteries become narrowed or stiffened by plaque, it can disrupt blood flow and impact everything from energy delivery to cognitive performance and immune resilience. At Superpower, we assess your risk and vascular health by measuring LDL cholesterol, ApoB, lipoprotein(a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), the atherogenic index of plasma (AIP), and the atherogenic coefficient (AC).LDL cholesterol, often called “bad cholesterol,” is a key carrier of cholesterol in the blood and a major contributor to plaque buildup. ApoB is a protein found on all atherogenic lipoproteins, providing a direct count of particles that can enter artery walls. Lp(a) is a genetic variant of LDL that is particularly prone to promoting plaque and clot formation. hs-CRP is a marker of low-grade inflammation, signaling immune activity that can destabilize plaques. AIP and AC are calculated ratios that reflect the balance between protective and harmful lipids, offering a broader view of your lipid-related risk. Healthy levels of these markers suggest stable arteries and efficient blood flow, supporting optimal function across body systems. Elevated or imbalanced results may indicate increased risk for atherosclerosis, even before symptoms appear, highlighting the importance of early detection. Interpretation of these biomarkers can be influenced by factors such as age, sex, pregnancy, acute illness, certain medications, and laboratory methods. These variables should be considered when evaluating your results.

Frequently Asked Questions

It’s a blood panel that screens how likely your arteries are to build plaque. Superpower tests your blood for LDL (low‑density lipoprotein cholesterol), ApoB (number of atherogenic particles), Lp(a) [genetic lipoprotein], hs‑CRP (high‑sensitivity C‑reactive protein, inflammation), AIP (Atherogenic index of plasma: log[TG/HDL‑C]), and AC (Atherogenic coefficient: non‑HDL/HDL). Together, these show particle burden, inherited risk, and vascular inflammation—core drivers of atherosclerosis.

Think in patterns. Lower ApoB and LDL mean fewer plaque‑forming particles. Elevated Lp(a) adds inherited risk regardless of LDL. Higher hs‑CRP indicates active vascular inflammation. Higher AIP and AC signal a more atherogenic lipoprotein balance. Combined, these markers estimate your plaque‑building pressure and inflammatory activity. Superpower provides clear, contextual explanations for your specific results.